本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MBX Biosciences

60.78
-0.3000-0.49%
成交量:33.00萬
成交額:2,021.05萬
市值:29.27億
市盈率:-25.27
高:62.75
開:61.34
低:59.68
收:61.08
52周最高:72.64
52周最低:9.64
股本:4,816.01萬
流通股本:2,762.99萬
量比:2.68
換手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
淨資產收益率:-33.17%
總資產收益率:-22.08%
市淨率:7.15
市盈率(LYR):-25.51

資料載入中...

2026/08/27

重要事件披露

Form 8-K - Current report
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities